temoporfin has been researched along with Skin Neoplasms in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (19.05) | 18.2507 |
2000's | 11 (52.38) | 29.6817 |
2010's | 5 (23.81) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Authors | Studies |
---|---|
Hamdoon, Z; Hopper, C; Jerjes, W; Yousif, AA | 1 |
Hamdoon, Z; Hopper, C; Jerjes, W | 1 |
Horlings, RK; Terra, JB; Witjes, MJ | 1 |
Albrecht, V; Betz, CS; Hopper, C; Nifantiev, NE; Rauschning, W; Riabov, MV; Stranadko, EP | 1 |
Dragicevic-Curic, N; Fahr, A; Gitter, B; Gräfe, S | 1 |
Hamdoon, Z; Hopper, C; Jerjes, W; Upile, T | 1 |
Albrecht, V; Betz, CS; Hopper, C; Nifantiev, NE; Rauschning, W; Riabov, MV; Stranadko, EP; Volgin, VN | 1 |
Bezdetnaya, LN; Coutier, S; Foster, TH; Guillemin, F; Parache, RM | 1 |
Bourré, L; Ferrand, Y; Lajat, Y; Odobel, F; Patrice, T; Simonneaux, G; Thibaut, S | 1 |
Baas, P; Haller, U; Klein, SD; Walt, H; Zimmermann, A | 1 |
Buchholz, J; Kaser-Hotz, B; Laluhová, D; Ohlerth, S; Roos, M; Walt, H | 1 |
Andersson-Engels, S; Axelsson, J; Bendsoe, N; Gräfe, S; Johansson, A; Persson, L; Svanberg, K; Svanberg, S; Svensson, J; Trebst, T | 1 |
Albrecht, V; Dragicevic-Curic, N; Fahr, A; Gräfe, S | 1 |
Bentley, MV; Primo, FL; Tedesco, AC | 1 |
Abramson, AL; Batti, J; Lee, CJ; Lofgren, LA; Nouri, M; Ronn, AM; Shikowitz, MJ; Steinberg, BM | 1 |
A'Amar, O; Bossu, E; Guillemin, F; Labrude, P; Notter, D; Parache, RM; Vigneron, C | 1 |
Haase, T; Kahle, B; Kübler, AC; Mühling, J; Rheinwald, M; Staff, C | 1 |
Gupta, G; MacKie, RM; Moore, JV; Morton, CA; Whitehurst, C | 1 |
Bossu, E; Guillemin, F; Notter, D; Padilla-Ybarra, JJ; Vigneron, C | 1 |
Morton, CA | 1 |
Baas, P; Neering, H; Oppelaar, H; Saarnak, AE; Stewart, FA | 1 |
1 review(s) available for temoporfin and Skin Neoplasms
Article | Year |
---|---|
mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2015 |
3 trial(s) available for temoporfin and Skin Neoplasms
Article | Year |
---|---|
Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2008 |
Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck.
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Laser Therapy; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prognosis; Prospective Studies; Radiation Dosage; Skin Neoplasms; Survival Rate; Treatment Outcome | 1999 |
Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Radiation Dosage; Skin Neoplasms; Treatment Outcome | 2001 |
17 other study(ies) available for temoporfin and Skin Neoplasms
Article | Year |
---|---|
Non-metastatic cutaneous squamous cell carcinoma treated with photodynamic therapy using intravenous mTHPC.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Infusions, Intravenous; Lasers, Semiconductor; Male; Mesoporphyrins; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Remission Induction; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Skin Neoplasms | 2019 |
Periorbital skin cancers subjected to mTHPC-photodynamic therapy: A prospective study.
Topics: Administration, Intravenous; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Male; Mesoporphyrins; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Neoplasms; Treatment Outcome | 2020 |
Efficacy of temoporfin-loaded invasomes in the photodynamic therapy in human epidermoid and colorectal tumour cell lines.
Topics: Cell Line, Tumor; Colorectal Neoplasms; Ethanol; Humans; Light; Liposomes; Mesoporphyrins; Microscopy, Confocal; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2010 |
Optical coherence tomography-guided photodynamic therapy for skin cancer: case study.
Topics: Carcinoma, Squamous Cell; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Tomography, Optical Coherence; Treatment Outcome | 2011 |
Long-term outcomes following Foscan®-PDT of basal cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lasers, Semiconductor; Male; Mesoporphyrins; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2012 |
Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Cell Hypoxia; Colonic Neoplasms; Dose-Response Relationship, Radiation; HT29 Cells; Humans; Lasers; Mesoporphyrins; Mice; Mice, Nude; Neoplasm Transplantation; Oxygen; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2002 |
Hydroporphyrins as tumour photosensitizers: synthesis and photophysical studies of 2,3-dihydro-5,15-di(3,5-dihydroxyphenyl) porphyrin.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Mesoporphyrins; Mice; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Porphyrins; Rats; Reference Standards; Skin Neoplasms; Spectrometry, Fluorescence; Tissue Distribution; Tumor Cells, Cultured | 2003 |
Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient.
Topics: Apoptosis; Breast Neoplasms; Carcinoma, Basal Cell; Floxuridine; Fluorouracil; Humans; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prostatic Neoplasms; Skin Neoplasms; Tumor Cells, Cultured | 2003 |
Changes in vascularity and blood volume as a result of photodynamic therapy can be assessed with power Doppler ultrasonography.
Topics: Animals; Blood Volume; Carcinoma, Squamous Cell; Cats; Female; Image Processing, Computer-Assisted; Male; Mesoporphyrins; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents; Skin; Skin Neoplasms; Ultrasonography, Doppler | 2006 |
Fluorescence monitoring of a topically applied liposomal Temoporfin formulation and photodynamic therapy of nonpigmented skin malignancies.
Topics: Administration, Topical; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorescence; Humans; Liposomes; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2007 |
Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot study.
Topics: Administration, Topical; Animals; Cell Line, Tumor; Ethanol; Female; Humans; Liposomes; Mesoporphyrins; Mice; Mice, Nude; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Skin Neoplasms; Terpenes; Tumor Burden | 2008 |
Photophysical studies and in vitro skin permeation/retention of Foscan/nanoemulsion (NE) applicable to photodynamic therapy skin cancer treatment.
Topics: Emulsions; Humans; In Vitro Techniques; Mesoporphyrins; Nanotechnology; Photosensitizing Agents; Skin; Skin Neoplasms; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 2008 |
Photodynamic therapy using m-tetra(hydroxyphenyl) chlorin. An animal model.
Topics: Animals; Antineoplastic Agents; Clinical Protocols; Cottontail rabbit papillomavirus; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Monitoring; Laryngeal Neoplasms; Mesoporphyrins; Papillomavirus Infections; Photochemotherapy; Rabbits; Skin Neoplasms; Time Factors; Tumor Virus Infections | 1994 |
Determination of the maximal tumor/normal skin ratio after HpD or m-THPC administration in hairless mouse (SKh-1) by fluorescence spectroscopy--a non-invasive method.
Topics: Animals; Antineoplastic Agents; Female; Hematoporphyrin Derivative; Mesoporphyrins; Mice; Mice, Hairless; Neoplasm Transplantation; Papilloma; Photochemotherapy; Skin; Skin Neoplasms; Spectrometry, Fluorescence | 1997 |
Photodynamic therapy with meso-tetra(hydroxyphenyl) chlorin in the topical treatment of Bowen's disease and basal cell carcinoma.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Female; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Skin Neoplasms | 1999 |
Determination of the maximal carcinoma/normal skin ratio after HpD or m-THPC administration in Hairless mice (SKH-1) by fluorescence spectroscopy.
Topics: Animals; Carcinoma; Disease Models, Animal; Female; Hematoporphyrins; Injections, Intraperitoneal; Mesoporphyrins; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Predictive Value of Tests; Skin; Skin Neoplasms; Spectrometry, Fluorescence; Tissue Distribution | 2000 |
Treating basal cell carcinoma: has photodynamic therapy come of age?
Topics: Carcinoma, Basal Cell; Humans; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2001 |